Triclosan treatment decreased the antitumor effect of sorafenib on hepatocellular carcinoma cells
Man Wu,1,2 Guanren Zhao,2 Xiaomei Zhuang,1 Tianhong Zhang,1 Ce Zhang,2 Wenpeng Zhang,1 Zhenqing Zhang1 1State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China; 2Department of Pharmacy, The 309th Hospital of PLA, Beijing, Chin...
Main Authors: | Wu M, Zhao G, Zhuang X, Zhang T, Zhang C, Zhang W, Zhang Z |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-05-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/triclosan-treatment-decreased-the-antitumor-effect-of-sorafenib-on-hep-peer-reviewed-article-OTT |
Similar Items
-
Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
by: Koen G. A. M. Hussaarts, et al.
Published: (2021-01-01) -
Oridonin Sensitizes Hepatocellular Carcinoma to the Anticancer Effect of Sorafenib by Targeting the Akt Pathway
by: Li X, et al.
Published: (2020-09-01) -
SOX9 enhances sorafenib resistance through upregulating ABCG2 expression in hepatocellular carcinoma
by: Mengchao Wang, et al.
Published: (2020-09-01) -
ARQ-197 enhances the antitumor effect of sorafenib in hepatocellular carcinoma cells via decelerating its intracellular clearance
by: Gao X, et al.
Published: (2019-02-01) -
CASK Silence Overcomes Sorafenib Resistance of Hepatocellular Carcinoma Through Activating Apoptosis and Autophagic Cell Death
by: Bisha Ding, et al.
Published: (2021-06-01)